Hyaluronic acid mediated adenoviral transduction

Details Hyaluronic acid mediated adenoviral transduction Hyaluronic acid mediated adenoviral transduction

2006-12-05

2006-12-05

Woitach, Joseph (Department: 1632)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C536S023100, C435S320100, C435S325000

Reexamination Certificate

active

07144870

ABSTRACT:
The present invention provides methods of treatment of adenoviral mediated disease, improved methods for transducing cells with adenoviral and related vectors, and improved methods of gene therapy utilizing such methods.

REFERENCES:
patent: 4141973 (1979-02-01), Balazs
patent: 4801619 (1989-01-01), Lindblad
patent: 4808526 (1989-02-01), Lawford
patent: 4840941 (1989-06-01), Ueno et al.
patent: 5670488 (1997-09-01), Gregory et al.
patent: 5824544 (1998-10-01), Armentano et al.
patent: 5932210 (1999-08-01), Gregory et al.
patent: 6194392 (2001-02-01), Falk et al.
patent: 6218373 (2001-04-01), Falk et al.
patent: 6258791 (2001-07-01), Braun
patent: 6271216 (2001-08-01), Mello et al.
patent: 6312681 (2001-11-01), Engler et al.
patent: 2001/0046965 (2001-11-01), Ayares et al.
patent: 2002/0004040 (2002-01-01), Kovesdi et al.
patent: 2131130 (1996-03-01), None
patent: WO 97/15330 (1997-05-01), None
Gunther, M et al. Curr Med Chem Anti-Cancer Agents 5(2):157-71, 2005.
Chevez-Barrios et al., “Gene therapy for retinoblastoma: comparison of gene repalcement with RB gene suicide gene,”Laboratory Investigation,80(3):198A, #1167, 2000.
Abe et al., “Transduction of a drug-sensitive toxic gene into human leukemia cell lines with a novel retroviral vector (43611),”Proc. Soc. Exp. Biol. Med.,203:354-359, 1993.
Banerjee et al. “Changes in growth and tumorigenicity following reconstitution of retinoblastoma gene function in various human cancer cell types by microcell transfer of chromosome 131,”Cancer Res.,52:6297-6304, 1992.
Behbakht et al., “Adenovirus-mediated gene therapy of ovarian cancer in a mouse model,”Am. J. Obstet. Gynecol.,175(5):1260-1265, 1996.
Bett et al., Packaging capacity and stability of human adenvirus type 5 vectors,J. Virol.,67(10):5911-5921, 1993.
Blackwell et al., “Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma,”Arch. Otolaryngol. Head. Neck Surg.,125(8):856-863, 1999.
Chen et al., “Combination gene therapy for liver metastasis of colon carcinoma in vivo,”Proc. Natl. Acad. Sci. USA,92(7):2577-2581, 1995.
Chen et al., “Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo,”Proc. Natl. Acad. Sci. USA,91(8):3054-3057, 1994.
Chillon et al., “Group D adenovirous infect primary central nervous system cells more efficiently than those from group C,”J. Virol.,73(3):2537-2540, 1999.
Chroboczek et al., “The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2,”Virology,186:280-285, 1992.
da Cruz et al., “Dynamics of gene transfer to retinal pigment epithelium,”Invest. Opthalmol. Vis. Sci.,37(12):2447-2454, 1996.
Dorai et al., “A recombinant defective adenoviral agent expressing anti-Bcl-2 ribozyme promotes apoptosis of Bcl-2-expressing human prostate cancer cells,”Int. J. Cancer,82(6):846-852, 1999.
Eastham et al., “Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models,”Hum. Gene Ther.,7(4):515-523, 1996.
Esandi et al., “Gene therapy of experimental malignant mesothelioma using adenovirous vectors encoding the HSVtk gene,”Gene Ther.,4(4):280-287, 1997.
Evans, “Latent adenovirus infections of the human respiratory tract,”Am. J. Hyg.67:256-263, 1958.
Feldman et al., “Perspectives of arterial gene therapy for the prevention of restenosis,”Cardiovasc. Res.,32(2):194-207, 1996.
Flomenberg et al., “Increasing incidence of adenovirus disease in bone marrow transplant recipients,”J. Infect. Dis.,169:775-781, 1994.
Goebel et al., “Adenovirus-mediated gene therapy for head and neck squamous cell carcinomas,”Ann. Otol. Rhinol. Laryngol.,105(7):562-567, 1996.
Goldstein et al, “Defective lipoprotein receptors and atherosclerosis-lessons from an animal counterpart of familial hypercholesterolemia,”New Engl. J. Med.,309(11983):288-296, 1983.
Graham and Prevec, “Methods for construction of adenovirus vectors,”Mol Biotechnol.,3(3):207-220, 1995.
Han et al., “Receptor-mediated gene transfer to cells of hepatic origin by galactosylated albumin-polylysine complexes,”Biol. Pharm. Bull.,22(8):836-840, 1999.
Hermens and Verhaagen, “Viral vectors, tools for gene transfer in the nervous system,”Prog. Neurobiol.,55(4):399-432, 1998.
Hoekstra, “Hyaluronan-modified surfaces for medical devices,”Medical Device&Diagnostic Industry Magazine,Feb. 1999.
Horwitz, In:Virology,2d edit., Fields (Ed.), Raven Press, Ltd. New York, 1990.
Hurwitz et al., “Suicide gene therapy for treatment of retinoblastoma in a murine model,”Hum. Gene Ther.,10:441-448, 1999.
Irie et al., “Therapeutic efficacy of an adenovirus-mediated anti-H-ras ribozyme in experimental bladder cancer,”Antisense Nucleic Acid Drug Dev.,9(4):341-349, 1999.
Ishibashi et al, “Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery,”J. Clin. Invest.,92:883-893, 1993.
Ishibashi et al, “Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice,”J. Clin. Invest.,93:1885-1893, 1994.
Kreil, “Hyalurnidases—a group of neglected enzymes,”Protein Sci.,4(9):1666-1669, 1995.
Laurent et al., (eds.)The Chemistry, Biology and Medical Applications of Hyaluronan and its Derivatives,Wenner-Gren Internatinal Series, vol. 72, c1998.
Lee and Spicer, “Hyaluronan: a multifunctional, megaDalton, stealth molecule,”Curr. Opin. Cell Biol.,12:581-586, 2000.
Lesch, “Gene transfer to the brain: emerging therapeutic strategy in psychiatry?”Biol Psychiatry,45(3):247-253, 1999.
Marienfeld et al., “Autoreplication of the vector genome in recombinant adenoviral vectors with different E1 region deletions and transgenes,”Gene Ther.,6(6):1101-1113, 1999.
Mincheff et al., “Naked DNA and adenoviral immunizations for immunotherapy of prostate cancer: a phase I/II clinical trial,”Eur. Urol.,38(2):208-217, 2000.
Morrison et al., “Complete DNA sequence of canine adenovirous type 1,”J. Gen. Virol.,78(Pt 4):873-878, 1997.
Neumann et al., “Detection of adenovirus nucleic acid sequence in human tonsils in the absence of infectious virus,”Virus Res.,7:93-97, 1987.
O'Malley et al., “Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model,”Cancer Res.,55(5):1080-1085, 1995.
Parks et al., “A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging,”J. Virol.,71(4):3293-3298, 1997.
Petrof, “Respiratory muscles as a target for adenovirus-mediated gene therapy,”Eur. Respir. J.,11(2):492-497, 1998.
Reddy et al., “Nucleotide sequence and transcription map of procine adenovirus type 3,”Virology,251(2):414-426, 1998.
Robbins et al., “Viral vectors for gene therapy,”Trends Biotechnol.,16(1):35-40, 1998.
Rooney et al., “Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation,”Lancet.,345:9-13, 1995.
Rosenfeld et al., “Adenoviral-mediated delivery of herpes simplex virus thymideine kinase results in tumor reduction and prolonged survival in a SCID mouse model of human ovarian carcinoma,”J. Mol. Med.,74(8):455-462, 1996.
Schmitz et al., “Worldwide epidemiology of human adenovirus infections,”Am. J. Epidemiol.,117-455-466, 1983.
Shiver et al., “Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity,”Nature,415:331-335, 2002.
SIGMA™ 2002-2003 Catalog of Biochemical and Rea

Affiliated with

Also associated with

Rating

Hyaluronic acid mediated adenoviral transduction does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hyaluronic acid mediated adenoviral transduction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hyaluronic acid mediated adenoviral transduction will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3663834